EN DE
STOCK COMPARISON

Krishana Phoschem vs Corteva: Fair Value & Quality

Both stocks run through our valuation models. Here is how Krishana Phoschem (KRISHANA) and Corteva (CTVA) compare, as of Aug 18, 2026.

As of Aug 18, 2026, Fair Value Calculator sees Krishana Phoschem as the less overvalued of the two: Krishana Phoschem trades at ₹187 versus a fair value of ₹97.17 (-48%), while Corteva trades at $76.01 versus $27.81 (-63%).
Krishana Phoschem
KRISHANA.NSE · INR · Materials
-48%
upside to fair value
overvalued
Price₹187
Fair Value₹97.17
Quality51/100
Corteva
CTVA · USD · Materials
-63%
upside to fair value
overvalued
Price$76.01
Fair Value$27.81
Quality71/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Krishana PhoschemCorteva
Valuation
32.2×P/E (TTM)46.3×
1.92×P/S (TTM)3.20×
8.28×P/B2.37×
15.2×EV/EBITDA13.2×
PEG1.44×
0.4%Dividend yield0.9%
₹0.50Dividend per share$0.72
Profitability
7%Net margin7%
13%Operating margin24%
38%Return on equity5%
13%Return on assets4%
Growth
60%Revenue growth (YoY)11%
119.0%Avg. growth/yr (3Y)-0.1%
74.9%Avg. growth/yr (5Y)4.1%
Balance & size
0.28×Debt / equity0.07×
$488MMarket cap$57B
expensiveGrowth qualityhealthy

Krishana Phoschem leads: 8 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Krishana Phoschemof which business quality 48 · market factors 16 Cortevaof which business quality 69 · market factors 58
ProfitabilityMargins and returns on capital today
75
30
Quality GrowthAre margins and returns improving?
63
48
CashflowEarnings quality: real cash, not paper profit
0
80
Fin. StrengthBalance sheet, leverage, solvency risk
47
74
InvestmentDisciplined investing over empire-building
28
97
Low VolatilityCalm price path (market factor)
50
84
MomentumPrice trend over the last 3–12 months (market factor)
0
45
52W MomentumDistance to the 52-week high (market factor)
5
49
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Krishana Phoschem

DCF Models₹113
Earnings-Based₹204
Dividend Discount₹1.76
Multiples₹99.07
Asset-Based₹12.15
Economic Profit₹105
Growth Earnings₹251

13 of 17 models see the stock below the current price.

Corteva

DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Krishana Phoschem
Bear ₹67.29Fair Value ₹97.17Bull ₹265
₹187 = current price (white tick)
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.01 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Krishana Phoschem · Materials

Quality score51 · above median
Fair value upside-48% · below median

Corteva · Materials

Quality score71 · Top 25%
Fair value upside-63% · bottom 25%

Bottom line

As of Aug 18, 2026, Fair Value Calculator sees Krishana Phoschem as the less overvalued of the two: Krishana Phoschem trades at ₹187 versus a fair value of ₹97.17 (-48%), while Corteva trades at $76.01 versus $27.81 (-63%).

Corteva has the higher quality score (71/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.